Ming‐Shyan Lin - Researcher Profile

Publications

2 shown

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Christopher P. Cannon , Michael A. Blazing , Robert P. Giugliano +18 more

When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to le...

2015 New England Journal of Medicine 4172 citations

BASELINE LDL-C AND CLINICAL OUTCOMES WITH ADDITION OF EZETIMIBE TO STATIN IN 18,144 PATIENTS POST ACS

Robert P. Giugliano , Christopher P. Cannon , Michael A. Blazing +6 more

2015 Journal of the American College of Ca... 7 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,179
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9348-8153

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.